PT Bundamedik Tbk (ISX:BMHS) Other Stockholders Equity: Rp909,262 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:BMHS PT Bundamedik Tbk ISX:BMHS
63 GF Score
Price Rp188.00
GF Value Rp261.49
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Other Stockholders Equity?

PT Bundamedik Tbk ISX:BMHS -0.53% 63 Other Stockholders Equity is Rp909,262 Mil as of Jun. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 63/100 and a GF Value™ of Rp261.49 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Bundamedik Tbk's Other Stockholders Equity for the quarter that ended in Jun. 2026 was Rp909,262 Mil.

PT Bundamedik Tbk's quarterly Other Stockholders Equity declined from Dec. 2025 (Rp909,406 Mil) to Mar. 2026 (Rp909,403 Mil) and declined from Mar. 2026 (Rp909,403 Mil) to Jun. 2026 (Rp909,262 Mil).

PT Bundamedik Tbk's annual Other Stockholders Equity declined from Dec. 2023 (Rp682,511 Mil) to Dec. 2024 (Rp679,760 Mil) but then increased from Dec. 2024 (Rp679,760 Mil) to Dec. 2025 (Rp909,406 Mil).

PT Bundamedik Tbk Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk Other Stockholders Equity Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 687,435.91 683,404.54 682,510.88 679,759.53 909,406.30

PT Bundamedik Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 679,104.32 677,938.19 909,406.30 909,402.62 909,262.15
ISX:BMHS
63GF Score
PT Bundamedik Tbk ISX:BMHS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of Rp909,262 Mil mean?
PT Bundamedik Tbk (ISX:BMHS) has a Other Stockholders Equity of Rp909,262 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's Other Stockholders Equity too high?
PT Bundamedik Tbk's current Other Stockholders Equity is Rp909,262 Mil. Overall, PT Bundamedik Tbk has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Other Stockholders Equity compare to HCA and THC?
PT Bundamedik Tbk's Other Stockholders Equity of Rp909,262 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current Other Stockholders Equity is Rp909,262 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp261.49, compared to a current price of Rp188.00 — trading 28.1% below its estimated fair value. The current Other Stockholders Equity is Rp909,262 Mil. PT Bundamedik Tbk's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Other Stockholders Equity is Rp909,262 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp188.00 is trading 28.1% below its estimated GF Value™ of Rp261.49. GuruFocus considers PT Bundamedik Tbk to be Modestly Undervalued.

Key valuation signals for ISX:BMHS:

  • Other Stockholders Equity: Rp909,262 Mil
  • GF Value™: Rp261.49 vs. price of Rp188.00 (28.1% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
63GF Score

Get the complete analysis for ISX:BMHS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp188.00
Price
Rp261.49
GF Value